1-159858113-C-T
Variant summary
Our verdict is Uncertain significance. Variant got 0 ACMG points: 2P and 2B. PM2BP4_Moderate
The NM_001013661.1(VSIG8):c.407G>A(p.Arg136Gln) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000217 in 1,614,182 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.
Frequency
Consequence
NM_001013661.1 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Uncertain_significance. Variant got 0 ACMG points.
Transcripts
RefSeq
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
VSIG8 | ENST00000368100.1 | c.407G>A | p.Arg136Gln | missense_variant | 3/7 | 1 | NM_001013661.1 | ENSP00000357080.1 | ||
ENSG00000256029 | ENST00000536779.5 | n.*64G>A | non_coding_transcript_exon_variant | 2/3 | 2 | ENSP00000456698.1 | ||||
ENSG00000256029 | ENST00000536779.5 | n.*64G>A | 3_prime_UTR_variant | 2/3 | 2 | ENSP00000456698.1 |
Frequencies
GnomAD3 genomes AF: 0.000138 AC: 21AN: 152174Hom.: 0 Cov.: 33
GnomAD3 exomes AF: 0.000103 AC: 26AN: 251456Hom.: 0 AF XY: 0.000103 AC XY: 14AN XY: 135906
GnomAD4 exome AF: 0.000226 AC: 330AN: 1461890Hom.: 0 Cov.: 34 AF XY: 0.000220 AC XY: 160AN XY: 727246
GnomAD4 genome AF: 0.000138 AC: 21AN: 152292Hom.: 0 Cov.: 33 AF XY: 0.000121 AC XY: 9AN XY: 74458
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Dec 03, 2024 | The c.407G>A (p.R136Q) alteration is located in exon 3 (coding exon 3) of the VSIG8 gene. This alteration results from a G to A substitution at nucleotide position 407, causing the arginine (R) at amino acid position 136 to be replaced by a glutamine (Q). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at